Approvals/CIMA-AEMPS/SOLIFENACINA/TAMSULOSINA VIATRIS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Approved

STANDARD

SOLIFENACINA/TAMSULOSINA VIATRIS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG

Viatris Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: bc505846af791020
Drug Cima Aemps Name: SOLIFENACINA/TAMSULOSINA VIATRIS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG
Register Number: 89055
Holder Company Name: Viatris Limited
Marketing Company Name: Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path: /organization/viatris-pharma-limited
Authorization Date: 2023-10-04
Dosage Form: COMPRIMIDO DE LIBERACIÓN MODIFICADA
Dose: 6 mg/0,4 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Viatris Limited
Company Detail Path: /organization/viatris-pharma-limited

SOLIFENACINA SUCCINATO

6 mg

TAMSULOSINA HIDROCLORURO

0,4 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 4, 2023

Approval ID

bc505846af791020

Type

Standard